Title of article :
Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: Role of 70-kDa S6 kinase and extracellular signal-regulated kinase
Author/Authors :
Shoji Sanada، نويسنده , , Koichi Node، نويسنده , , Hiroshi Asanuma، نويسنده , , Hisakazu Ogita، نويسنده , , Seiji Takashima، نويسنده , , Tetsuo Minamino، نويسنده , , Masanori Asakura، نويسنده , , Yulin Liao، نويسنده , , Akiko Ogai، نويسنده , , Jiyoong Kim، نويسنده , , Masatsugu Hori، نويسنده , , Masafumi Kitakaze، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2002
Abstract :
Objectives
We examined whether the adenosine triphosphate (ATP)-sensitive potassium (KATP) channel openers (KCOs) block myocardial hypertrophy and whether the 70-kDa S6 kinase (p70S6K) or extracellular signal-regulated kinase (ERK)-dependent pathway is involved.
Background
Long-term inhibition of nitric oxide (NO) synthesis induces cardiac hypertrophy independent of blood pressure, by increasing protein synthesis in vivo. The KCOs attenuate calcium overload and confer cardioprotection against ischemic stress, thereby preventing myocardial remodeling.
Methods
Twelve Wistar-Kyoto rat groups underwent eight weeks of the drug treatment in combination with the NO synthase inhibitor Nω-nitro-image-arginine methyl ester (image-NAME), the inactive isomer imageω-nitro-image-arginine methyl ester, KCOs (nicorandil, 3 and 10 mg/kg per day, or JTV-506, 0.3 mg/kg per day), or the KATP channel blocker glibenclamide. The image-NAME was also used with hydralazine, the p70S6K inhibitor rapamycin, or the mitogen-activated protein kinase inhibitor PD98059. Finally, the left ventricular weight (LVW) to body weight (BW) ratio was quantified, followed by histologic examination and kinase assay.
Results
The image-NAME increased blood pressure and LVW/BW, as compared with the control agent. The KCOs and hydralazine equally cancelled the increase in blood pressure, whereas only KCOs blocked the increase in LVW/BW and myocardial hypertrophy induced by image-NAME. The image-NAME group showed both p70S6K and ERK activation in the myocardium (2.3-fold and 2.0-fold increases, respectively), as compared with the control group, which was not reversed by hydralazine. Selective inhibition of either p70S6K or ERK blocked myocardial hypertrophy. The KCOs prevented the increase in activity only of p70S6K. Glibenclamide reversed the effect of nicorandil in the presence of image-NAME.
Conclusions
The KCOs modulate p70S6K, not ERK, to attenuate myocardial hypertrophy induced by long-term inhibition of NO synthesis in vivo.
Keywords :
ERK , BW , p70S6K , body weight , 70-kDa S6 kinase , D -NAME , PKC , KATP , Extracellular signal-regulated kinase , D ?-nitro-L -arginine methyl ester , protein kinase C , adenosine triphosphate-sensitive potassium , KCO , adenosine triphosphate-sensitive potassium channel opener , N?-nitro-L -arginine methyl ester , L -NAME , ANOVA , LVW , Analysis of variance , left ventricular weight , adenosine triphosphate , nitric oxide , ATP , NO
Journal title :
JACC (Journal of the American College of Cardiology)
Journal title :
JACC (Journal of the American College of Cardiology)